Literature DB >> 15245429

Human epidermal langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase.

Dagmar von Bubnoff1, Huguette Bausinger, Heike Matz, Susanne Koch, Georg Häcker, Osamu Takikawa, Thomas Bieber, Daniel Hanau, Henri de la Salle.   

Abstract

Langerhans cells (LC) are a special subset of dendritic cells integrating cutaneous immunity. The study of LC function is of major interest not only for efforts of vaccine design and immunotherapy but also for gaining an insight into the pathogenesis of immune-mediated cutaneous diseases and neoplasias. Recently, defined antigen-presenting cells were described that express indoleamine 2,3-dioxygenase (IDO) and inhibit T cell proliferation in vitro and in vivo. Here, we show that stimulation with interferon-gamma (IFN-gamma) induces the expression of functionally active IDO in highly purified human epidermal LC. The induction of IDO after stimulation of LC with IFN-gamma seems to follow a defined kinetic with rapid upregulation followed by a downregulation after about 24 h of culture. Accordingly, proliferation of T cells induced by anti-CD3 antibodies was modulated by supernatants of IFN-gamma-activated human epidermal LC. Importantly, downregulation of T cell proliferation by supernatants of 24 h IFN-gamma-activated LC was prevented by inhibition of IDO. These results indicate that LC not only have the capacity to stimulate but also to inhibit T cells, and suggest that LC possess an immunoregulatory function in promoting T cell tolerance by production of IDO.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15245429     DOI: 10.1111/j.0022-202X.2004.23217.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

1.  Specialized role of migratory dendritic cells in peripheral tolerance induction.

Authors:  Juliana Idoyaga; Christopher Fiorese; Lori Zbytnuik; Ashira Lubkin; Jennifer Miller; Bernard Malissen; Daniel Mucida; Miriam Merad; Ralph M Steinman
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

Review 2.  Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege.

Authors:  Lei Huang; Babak Baban; Burles A Johnson; Andrew L Mellor
Journal:  Int Rev Immunol       Date:  2010-04       Impact factor: 5.311

Review 3.  Human skin and oral mucosal dendritic cells as 'good guys' and 'bad guys' in allergic immune responses.

Authors:  N Novak; E Gros; T Bieber; J-P Allam
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

4.  Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells.

Authors:  Mercedes Gomez de Agüero; Marc Vocanson; Fériel Hacini-Rachinel; Morgan Taillardet; Tim Sparwasser; Adrien Kissenpfennig; Bernard Malissen; Dominique Kaiserlian; Bertrand Dubois
Journal:  J Clin Invest       Date:  2012-04-23       Impact factor: 14.808

Review 5.  Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.

Authors:  Burles A Johnson; Babak Baban; Andrew L Mellor
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

Review 6.  IDO-expressing regulatory dendritic cells in cancer and chronic infection.

Authors:  Alexey Popov; Joachim L Schultze
Journal:  J Mol Med (Berl)       Date:  2007-09-18       Impact factor: 4.599

7.  Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation.

Authors:  Jillian Emmons; W H Davin Townley-Tilson; Kristen M Deleault; Stephen J Skinner; Robert H Gross; Michael L Whitfield; Seth A Brooks
Journal:  RNA       Date:  2008-03-26       Impact factor: 4.942

8.  Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10.

Authors:  Botond Z Igyarto; Matthew C Jenison; Jan C Dudda; Axel Roers; Werner Müller; Pandelakis A Koni; Daniel J Campbell; Mark J Shlomchik; Daniel H Kaplan
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

9.  Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.

Authors:  David J Chung; Marco Rossi; Emanuela Romano; Jennifer Ghith; Jianda Yuan; David H Munn; James W Young
Journal:  Blood       Date:  2009-05-22       Impact factor: 22.113

10.  Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation?

Authors:  Marina Scheler; Joerg Wenzel; Thomas Tüting; Osamu Takikawa; Thomas Bieber; Dagmar von Bubnoff
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.